Construction and verification of a novel circadian clock related long non-coding RNA model and prediction of treatment for survival prognosis in patients with hepatocellular carcinoma

被引:7
|
作者
Zhang, Zhen [1 ]
Gao, Wenhui [2 ]
Tan, Xiaoning [1 ]
Deng, Tianhao [1 ]
Zhou, Wanshuang [1 ]
Jian, Huiying [2 ]
Zeng, Puhua [1 ]
机构
[1] Hunan Acad Tradit Chinese Med, Affiliated Hosp, Dept Oncol, Changsha 410006, Peoples R China
[2] Hunan Univ Chinese Med, Sch Chinese Med, Changsha 410208, Peoples R China
基金
中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Circadian clock; lncRNA; Immune infiltration; Risk model; CANCER; PROLIFERATION; EXPRESSION; CELLS;
D O I
10.1186/s12885-023-10508-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circadian clock genes are significant in the occurrence and development of HCC and long-non coding RNAs (lncRNAs) are closely related to HCC progression. In this study, we aimed to establish a prognostic risk model for HCC. Circadian clock-related lncRNAs expressed in HCC were extracted from The Cancer Genome Atlas. A nomogram was established to predict individual survival rate. Biological processes enriched for risk model transcripts were investigated by Gene Set Enrichment Analysis. Further, we evaluated the relationship between risk score and immune-checkpoint inhibitor-related gene expression level. The Genomics of Drug Sensitivity in Cancer (GDSC) database was used to assess the sensitivity of tumors in high- and low-risk score groups to different drugs. A total of 11 circadian clock-related lncRNAs were included in multi-Cox proportional hazards model analysis to establish a risk model. Univariate and multivariate Cox regression analysis showed that the risk model was an independent risk factor in HCC. The risk model was a significantly associated with the immune signature. Further GDSC analysis indicated that patients in each risk score group may be sensitive to different anti-cancer drugs. QRT-PCR analysis results showed that C012073.1, PRRT3-AS1, TMCC1-AS1, LINC01138, MKLN1-AS, KDM4A-AS1, AL031985.3, POLH-AS1, LINC01224, and AC099850.3 were more highly expressed in Huh-7 and HepG2, compared to LO2, while AC008549.1 were lower expressed. Our work established a prognostic model for HCC. Risk score analysis indicated that the model is significantly associated with modulation tumor immunity and could be used to guide more effective therapeutic strategies in the future.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] The development and validation of a novel senescence-related long-chain non-coding RNA (lncRNA) signature that predicts prognosis and the tumor microenvironment of patients with hepatocellular carcinoma
    Huang, Enmin
    Ma, Tao
    Zhou, Junyi
    Ma, Ning
    Yang, Weisheng
    Liu, Chuangxiong
    Hou, Zehui
    Chen, Shuang
    de Castria, Tiago Biachi
    Zeng, Bing
    Zong, Zhen
    Zhou, Taicheng
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (14)
  • [42] EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database
    Zhang, Zonglin
    Wang, Surong
    Liu, Wenqi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) : 1530 - 1536
  • [43] Inflammation-Related Long Non-Coding RNA Signature Predicts the Prognosis of Gastric Carcinoma
    Zhang, ShuQiao
    Li, XinYu
    Tang, ChunZhi
    Kuang, WeiHong
    FRONTIERS IN GENETICS, 2021, 12
  • [44] Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma
    Wang, Xiaodong
    Qian, Jing
    Yao, Ninghua
    Pocha, Christine
    Kang, Koo Jeong
    Angelico, Roberta
    Zhu, Guodong
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (10)
  • [45] Identification of long non-coding RNA-related and –coexpressed mRNA biomarkers for hepatocellular carcinoma
    Fan Zhang
    Linda Ding
    Li Cui
    Robert Barber
    Bin Deng
    BMC Medical Genomics, 12
  • [46] Identification of long non-coding RNA-related and -coexpressed mRNA biomarkers for hepatocellular carcinoma
    Zhang, Fan
    Ding, Linda
    Cui, Li
    Barber, Robert
    Deng, Bin
    BMC MEDICAL GENOMICS, 2019, 12 (Suppl 1)
  • [47] Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma
    Wu, Zeng-Hong
    Li, Zi-Wei
    Yang, Dong-Liang
    Liu, Jia
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [48] Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma
    Huang, Jin-Lan
    Zheng, Lei
    Hu, Yan-Wei
    Wang, Qian
    CARCINOGENESIS, 2014, 35 (03) : 507 - 514
  • [49] Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis
    Tian, Yu
    Zhang, Meng
    Liu, Li-xia
    Wang, Zi-chao
    Liu, Bin
    Huang, Youcai
    Wang, Xiaoling
    Ling, Yun-zhi
    Wang, Furong
    Feng, Xiaoqiang
    Tu, Yanyang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [50] Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer
    Li, Qiuying
    Li, Haihong
    Zhang, Lu
    Zhang, Chunming
    Yan, Wentao
    Wang, Chao
    ONCOTARGET, 2017, 8 (28) : 46136 - 46144